NCT04911621 Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04865315 A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors Status RECRUITING Phase N/A
NCT04766632 Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas Status COMPLETED Phase NA
NCT04655404 A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Status RECRUITING Phase EARLY_PHASE1
NCT04608812 Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection Status TERMINATED Phase PHASE1
NCT04573140 A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) Status RECRUITING Phase PHASE1
NCT04559685 Study of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma Status TERMINATED Phase EARLY_PHASE1
NCT04485559 Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) Status SUSPENDED Phase PHASE1
NCT04482933 HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma Status WITHDRAWN Phase PHASE2
NCT04267146 Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT04254419 Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells Status RECRUITING Phase PHASE1
NCT04220892 Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma Status WITHDRAWN Phase EARLY_PHASE1
NCT04099797 C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) Status RECRUITING Phase PHASE1
NCT03973918 Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG Status TERMINATED Phase PHASE2
NCT03971734 Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas Status TERMINATED Phase PHASE1
NCT03952598 Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy Status SUSPENDED Phase PHASE2